| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(91)90033-U |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:009286749190033U?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:009286749190033U?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1717155 |
| P50 | author | Judah Folkman | Q710619 |
| François Radvanyi | Q61820731 | ||
| P2093 | author name string | M. Klagsbrun | |
| Bossy-Wetzel E | |||
| J. Kandel | |||
| D. Hanahan | |||
| E. Bossy-Wetzel | |||
| P2860 | cites work | Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth | Q24295049 |
| The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors | Q24297432 | ||
| High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons | Q24621303 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 | ||
| The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein | Q27939661 | ||
| Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | Q28267322 | ||
| An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family | Q28285491 | ||
| What Is the Evidence That Tumors Are Angiogenesis Dependent? | Q29620029 | ||
| Angiogenic factors | Q29620582 | ||
| Long-term culture of capillary endothelial cells | Q34038077 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| Specific chromosomal abnormalities characterize fibrosarcomas of bovine papillomavirus type 1 transgenic mice | Q34286617 | ||
| Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture | Q34307133 | ||
| Induction of angiogenesis during the transition from hyperplasia to neoplasia | Q34413571 | ||
| Isolation of cDNAs encoding four mouse FGF family members and characterization of their expression patterns during embryogenesis | Q34489125 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors | Q34594024 | ||
| Growth factors are released by mechanically wounded endothelial cells | Q36221181 | ||
| Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism | Q36383370 | ||
| Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome | Q36767326 | ||
| Localization and analysis of bovine papillomavirus type 1 transforming functions | Q36895431 | ||
| Molecular themes in oncogenesis | Q37625792 | ||
| Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors | Q37676846 | ||
| The biochemistry of P-glycoprotein-mediated multidrug resistance | Q38364215 | ||
| Transgenic mice as probes into complex systems | Q38727464 | ||
| Dissecting multistep tumorigenesis in transgenic mice | Q39569967 | ||
| Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor | Q42817191 | ||
| Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography | Q42817240 | ||
| The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage | Q42831631 | ||
| Bovine papillomavirus genome elicits skin tumours in transgenic mice | Q44991828 | ||
| Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. | Q53760372 | ||
| Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: Inhibition of tumor growth by antibodies to FGF | Q56429264 | ||
| Potential oncogene product related to growth factors | Q59096204 | ||
| Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted | Q69061239 | ||
| The genes for basic and acidic fibroblast growth factors are on different human chromosomes | Q69585939 | ||
| Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor | Q72726491 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neovascularization | Q1281049 |
| P304 | page(s) | 1095-1104 | |
| P577 | publication date | 1991-09-01 | |
| 1991-09-20 | |||
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma | |
| P478 | volume | 66 |
| Q34038752 | A case of large solitary fibrous tumor in the retroperitoneum. |
| Q39444483 | A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. |
| Q27930241 | A new pathway for protein export in Saccharomyces cerevisiae |
| Q36222472 | A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. |
| Q37697226 | A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development. |
| Q41839581 | Accelerating nonlinear reconstruction in laminar optical tomography by use of recursive SVD inversion |
| Q24647014 | Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes |
| Q42792380 | An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors |
| Q34655335 | Angiogenesis and antiangiogenic agents in cervical cancer. |
| Q35091135 | Angiogenesis and apoptosis |
| Q40949301 | Angiogenesis and the skin: a primer |
| Q40963683 | Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies |
| Q96135356 | Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment |
| Q34735895 | Angiogenesis in Endocrine Neoplasms |
| Q29547165 | Angiogenesis in cancer, vascular, rheumatoid and other disease |
| Q35838969 | Angiogenesis induced by signal transducer and activator of transcription 5A (STAT5A) is dependent on autocrine activity of proliferin |
| Q40927698 | Angiogenesis inhibitors generated by tumors. |
| Q35168751 | Angiogenesis: A mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis |
| Q45876855 | Angiostatin gene therapy inhibits the growth of murine squamous cell carcinoma in vivo |
| Q41126050 | Anti-invasion drugs |
| Q28067001 | Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review |
| Q40958598 | Antiangiogenesis as a novel therapeutic concept in pediatric oncology |
| Q35687692 | Antiangiogenic strategies, compounds, and early clinical results in breast cancer |
| Q37707900 | Antiangiogenic therapy of transgenic mice impairs de novo tumor growth |
| Q53721797 | Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells. |
| Q73314442 | Basic FGF and Ki‐67 proteins useful for immunohistological diagnostic evaluations in malignant solitary fibrous tumor |
| Q40834153 | Basics of cutaneous wound repair |
| Q42065432 | Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis |
| Q45857897 | Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth |
| Q33888191 | Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. |
| Q35737411 | Biologic therapy of liver tumors |
| Q36673732 | Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers. |
| Q42100537 | CNTF receptor alpha is expressed by magnocellular neurons and expression is upregulated in the rat supraoptic nucleus during axonal sprouting |
| Q71795852 | Calmodulin and In Vitro Regenerating Frog Sciatic Nerves: Release and Extracellular Effects |
| Q28209252 | Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression |
| Q74012709 | Characterization and modulation of LP(a) in human hepatoma HEPG2 cells |
| Q42818080 | Characterization of fibroblast growth factor-2 binding to ribosomes |
| Q43756598 | Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer |
| Q40392096 | Clinical prognostic significance of tumour angiogenesis |
| Q77560781 | Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome |
| Q35863426 | Cloning of a cDNA for the FAD-linked glycerol-3-phosphate dehydrogenase from rat liver and its regulation by thyroid hormones |
| Q48049656 | Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. |
| Q28211085 | Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas |
| Q40958445 | Current and future strategies to block tumor angiogenesis, invasion, and metastasis |
| Q41111895 | Cytokines in tumour growth, migration and metastasis |
| Q41732190 | DMBA-induced mammary pathologies are angiogenic in vivo and in vitro |
| Q61771867 | Decorin suppresses tumor cell-mediated angiogenesis |
| Q72130906 | Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability |
| Q46146329 | Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis |
| Q45882308 | Development of lentiviral vectors for antiangiogenic gene delivery |
| Q49544357 | Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer. |
| Q52516638 | Disruption of the CNTF gene results in motor neuron degeneration. |
| Q40970487 | Dual activities of 22-24 kDA basic fibroblast growth factor: inhibition of migration and stimulation of proliferation |
| Q41085209 | Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines |
| Q36134876 | Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells |
| Q71728153 | Elevated levels of basic fibroblast growth factor in patients with limb ischemia |
| Q39535416 | Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival |
| Q24315369 | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth |
| Q45880325 | Endothelial cell-based systemic gene therapy of metastatic melanoma |
| Q36375147 | Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells |
| Q73407623 | Enhancement of bFGF export associated with malignant progression of human salivary gland cell clones |
| Q73058480 | Evaluation of omental implantation for perforated gastric ulcer therapy: findings in a rat model |
| Q24602640 | Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy |
| Q37378717 | Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases |
| Q73043529 | Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers |
| Q72523312 | Expression of basic fibroblast growth factor in hyperplastic parathyroid glands from patients with multiple endocrine neoplasia type I |
| Q36832783 | Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularization |
| Q71911447 | Expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 messenger RNAs in spinal ganglia and sciatic nerve: regulation after peripheral nerve lesion |
| Q78010550 | Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3'-untranslated region between alternative polyadenylation sites |
| Q73708839 | Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis |
| Q37981986 | FGF receptor inhibitors: role in cancer therapy |
| Q33791689 | Factors promoting tumor angiogenesis |
| Q35838014 | Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. |
| Q60671986 | Fibroblast growth factor 2 and the protease activity of tumor cells isolated from BK virus/tat transgenic mice |
| Q24683914 | Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation |
| Q41251287 | Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis |
| Q29616827 | Fibroblast growth factor signalling: from development to cancer |
| Q63286769 | Fibroblast growth factors |
| Q33905997 | Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium |
| Q34621100 | From antiangiogenesis to hypoxia: current research and future directions |
| Q24681517 | Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation |
| Q73128209 | Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL |
| Q40398319 | Growth factor targeted and conventional therapy of breast cancer |
| Q40418085 | Growth factors in the CNS and their effects on oligodendroglia |
| Q34166251 | Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers |
| Q37293193 | Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells |
| Q33537473 | Homeostatic control of angiogenesis: A newly identified function of the liver? |
| Q41100541 | How tumors become angiogenic |
| Q33863829 | Human fibroblast growth factor-18 stimulates fibroblast cell proliferation and is mapped to chromosome 14p11. |
| Q41940732 | Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. |
| Q42826102 | IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition |
| Q79274403 | Immunohistochemical Expression of p53, Fibroblast Growth Factor-b, and Transforming Growth Factor-α in Feline Vaccine-associated Sarcomas |
| Q35765199 | Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study |
| Q36006469 | Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells |
| Q33555860 | Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation |
| Q36623745 | Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma |
| Q44259989 | Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. |
| Q34109863 | Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis |
| Q40561055 | Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes |
| Q40330266 | Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes |
| Q34211515 | Inhibition of endothelial cell activation by the homeobox gene Gax. |
| Q28578750 | Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth |
| Q41168278 | Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q55266412 | Interaction of interleukin-1 and interferon-gamma on fibroblast growth factor-induced angiogenesis. |
| Q40461268 | Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. |
| Q35610493 | Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth |
| Q73747954 | Interleukin-1beta immunoreactivity in identified neurons of the rat magnocellular neurosecretory system: evidence for activity-dependent release |
| Q35796301 | Intratumor microvessel density as a prognostic factor in cancer |
| Q37366828 | Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels |
| Q41140331 | Liver endothelial cells: participation in host response to lymphoma metastasis |
| Q59137746 | Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth |
| Q42805105 | Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells |
| Q36431354 | Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma |
| Q91860487 | Lycopene enriched tomato extract suppresses chemically induced skin tumorigenesis in mice |
| Q35833248 | Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. |
| Q73441686 | Matrix metalloproteinase inhibitors |
| Q41142376 | Medical therapy of genital human papilloma virus-related disease |
| Q35159008 | MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization |
| Q48089840 | Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours |
| Q35790781 | Molecular biological design of novel antineoplastic therapies |
| Q34178900 | Molecular mechanisms of tumor angiogenesis and tumor progression |
| Q40508667 | Multimodality treatment of extra-visceral soft tissue sarcomas M0: state of the art and trends |
| Q42997083 | N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface |
| Q37368066 | Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis |
| Q41121027 | Oncogenes as inducers of tumor angiogenesis |
| Q35964906 | Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways |
| Q81004145 | Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis |
| Q90164261 | PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma |
| Q42809831 | Pancreatic beta cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines |
| Q29547178 | Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis |
| Q42815983 | Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors |
| Q78439681 | Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes |
| Q44043459 | Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin |
| Q41126678 | Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). |
| Q73074317 | Pleiotropic over-expression of multidrug-resistance-related genes is correlated to MYCN and max mRNA accumulation during tumour progression in the IGR-N-91 human neuroblastoma model |
| Q40901139 | Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors |
| Q35120835 | Positive and negative regulation of cellular sensitivity to anti-cancer drugs by FGF-2 |
| Q44595847 | Positive effects of phenytoin on experimental colonic anastomoses |
| Q54677168 | Preparation and biological properties of native and recombinant ciliary neurotrophic factor |
| Q54573164 | Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study. |
| Q41679425 | Proposal for a new model of breast cancer metastatic development |
| Q35782383 | Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment |
| Q36114954 | Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer |
| Q28275289 | R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways |
| Q38929341 | RORα inhibits adipocyte-conditioned medium-induced colorectal cancer cell proliferation and migration and chick embryo chorioallantoic membrane angiopoiesis |
| Q33949075 | Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression |
| Q67542400 | Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF) |
| Q41372654 | Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis |
| Q35547829 | Relaxin‐like peptides in cancer |
| Q44938165 | Release and subcellular localization of acidic fibroblast growth factor expressed to high levels in HeLa cells |
| Q35902765 | Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor. |
| Q41372610 | Role of soluble mediators in angiogenesis |
| Q43714114 | Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells |
| Q42454728 | Stage-dependent expression of an angiogenic agent and vascular organization in experimental skin tumor development |
| Q58659194 | Stromelysin-3 Is Induced in Tumor/Stroma Cocultures and Inactivated via a Tumor-specific and Basic Fibroblast Growth Factor-dependent Mechanism |
| Q42168171 | Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor |
| Q33861490 | Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis |
| Q35108335 | Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes |
| Q43933934 | Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma |
| Q44126549 | Synthesis and structure-activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human endothelial cells |
| Q35141837 | T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells |
| Q34060827 | Targeting tumor blood vessels: an adjuvant strategy for radiation therapy |
| Q36037600 | The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years |
| Q59219523 | The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression |
| Q36600928 | The history of the angiogenic switch concept |
| Q40930912 | The influence of angiogenesis research on management of patients with breast cancer |
| Q36421743 | The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue |
| Q38540713 | The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. |
| Q41508912 | The preclinical evaluation of angiogenesis inhibitors |
| Q72011825 | The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas |
| Q35168748 | The role of fibroblast growth factors and related oncogenes in tumor growth |
| Q40442587 | The role of growth factors in proliferative diabetic retinopathy |
| Q33997842 | The role of the vascular phase in solid tumor growth: a historical review |
| Q40401867 | The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis |
| Q36627750 | The tumor microenvironment: key to early detection |
| Q40241912 | The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. |
| Q40401362 | Transcriptional expression of the genes implicated in angiogenesis and tumor invasion in cervical carcinomas |
| Q40606994 | Transfected MCF-7 cells as a model for breast-cancer progression |
| Q41372600 | Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models |
| Q36237738 | Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells |
| Q34806680 | Translational control of gene expression: role of IRESs and consequences for cell transformation and angiogenesis |
| Q36244418 | Tumor angiogenesis and molecular target therapy in ovarian carcinomas |
| Q35250910 | Tumor angiogenesis as a target for dietary cancer prevention |
| Q74128408 | Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma |
| Q41140281 | Tumor angiogenesis: a physiological process or genetically determined? |
| Q41111904 | Tumor angiogenesis: the pivotal role of vascular endothelial growth factor |
| Q40044331 | Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. |
| Q71632371 | Tumour angiogenesis |
| Q71802890 | Tumour dormancy: not so sleepy after all |
| Q40911311 | Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer |
| Q73787278 | Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism |
| Q33989013 | Ultrastructural immunolocalization of basic fibroblast growth factor in endothelial cells: morphologic evidence for unconventional secretion of a novel protein |
| Q72913275 | Ultraviolet radiation-induced corneal tumours in the South American opossum, Monodelphis domestica |
| Q42321526 | Understanding Dupuytren's Disease Using Systems Biology: A Move Away from Reductionism |
| Q39570902 | Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma |
| Q58212211 | Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival |
| Q40706795 | Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease |
| Q40941320 | Vascular remodelling and molecular biology: new concepts and therapeutic possibilities |
| Q35104368 | Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes |
| Q37257230 | Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis |
| Q72898097 | bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice |
| Q73798288 | bFGF and tumor angiogenesis--back in the limelight? |
Search more.